CHELSEA HOOVER: Open Payments
NPI 1497366744 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,477 in 127 payments from 20 companies in 2025. Trend: 2023 $2,705 · 2024 $2,914 · 2025 $2,477
Food & beverage: $2,277Education: $200
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 25 | $407 |
| GENZYME CORPORATION | 12 | $378 |
| Regeneron Healthcare Solutions, Inc. | 13 | $346 |
| ABBVIE INC. | 14 | $198 |
| LEO Pharma Inc. | 9 | $189 |
| Janssen Biotech, Inc. | 7 | $184 |
| Galderma Laboratories, L.P. | 19 | $148 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $111 |
| Amgen Inc. | 4 | $75 |
| Lilly USA, LLC | 3 | $68 |
Products named: DUPIXENT, COSENTYX, TREMFYA, ADBRY, NEMLUVIO, SKYRIZI, OTEZLA, RINVOQ.
Industry payments across AL — which companies pay providers there.
